News

BALKAN PHARMACEUTICALS IS WIDENING ITS PORTFOLIO OF MEDICINES

BALKAN PHARMACEUTICALS IS WIDENING ITS PORTFOLIO OF MEDICINES

  • The expansion of the range of manufactured medicines is one of the main goals of Balkan Pharmaceuticals, which contributes to ensuring the pharmaceutical security of the Republic of Moldova and diminishing the dependence on imported drugs.



    The Medicines and Medical Devices Agency authorized, by Order No. 126 of 18 May 2018, eight new Balkan Pharmaceuticals medicines, two of which are Moldovans’ number one choice in healing headaches - Citramon BP (tablets) and Citramon BP Forte (tablets).



    At the same time, other products have been authorized including:

    - Algodex (25 mg / ml, 2 ml, N5 / N10 solution for injection);

    - Lisinopril-BP (5mg, N14 / N28 tablets)

    - Lisinopril-BP (10mg, N14 / N28 tablets)

    - Lisinopril-BP (20 mg tablets, N14 / N28 tablets)

    - Propandrol (100 mg / ml, 1 ml, N10 solution for injection)

    - Propandrol (100 mg / ml, 10 ml, N1 solution for injection)

IMPORTANT NOTE

11111

Due to the increasing reports of fraud using the Balkan Pharmaceuticals trademark, we inform you that:

  1. The ONLY official website of the company is https://balkanpharmaceuticals.com/
  2. Balkan Pharmaceuticals does NOT sell products through online stores and e-mails
  3. Balkan Pharmaceuticals does NOT ship packages and does NOT request payments through Western Union, MoneyGram or other international transfer systems (SWIFT, BTC, Crypto currencies) 
  4. All employees at Balkan Pharmaceuticals exclusively use corporate email addresses with domain @balkanpharmaceuticals.com. Please check this when responding to e-mails. Any request to make contact through other addresses is an attempt of fraud!
  5. We recommend that you learn about the latest methods of protection of Balkan Pharmaceuticals products, as well as verify the authenticity of our products, via https://b-p.md/

The health of our patience is our type priority.